Veracyte Publishes Data Supporting Clinical Use of Percepta Lung Cancer Dx | GenomeWeb

NEW YORK (GenomeWeb) — Veracyte and a team of academic collaborators reported yesterday clinical data showing that the company's microarray-based Percepta Bronchial Genomic Classifier, which uses a 23-gene panel to identify patients at low risk of cancer following an inconclusive bronchoscopy result, may help prevent unnecessary invasive procedures.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Dec
06
Sponsored by
Natera

This webinar will discuss a partnership model for noninvasive prenatal testing that enabled LifeLabs Genetics, a genetic testing lab based in Toronto, Ontario, to implement NIPT in house.